首页 | 本学科首页   官方微博 | 高级检索  
检索        

89SrCl2联合"云克"治疗前列腺癌骨转移的临床价值
引用本文:朱文茹,郑飞波,柳炳吉,戴锦朝.89SrCl2联合"云克"治疗前列腺癌骨转移的临床价值[J].标记免疫分析与临床,2011,18(4):241-243.
作者姓名:朱文茹  郑飞波  柳炳吉  戴锦朝
作者单位:青岛大学医学院第二附属医院核医学科,山东,青岛,266042
摘    要:为探讨89SrCl2联合"云克"治疗前列腺癌多发骨转移的临床价值,将95例前列腺癌骨转移患者分为89SrCl2组(A组)46例,89SrCl2加"云克"组(B组)49例.治疗后随访患者的骨痛缓解情况、全身骨显像的变化情况以及前列腺特异抗原(PSA)变化情况.结果显示,B组患者骨痛缓解的总有效率为87.76%,骨显像完全...

关 键 词:锶-89  云克  骨转移  前列腺癌

Clinical Value of Strontium-89 Combined with 99Tc-MDP in Treatment of Bone Metastases of Prostate Cancer
ZHU Wen-ru,ZHENG Fei-bo,LIU Bing-ji,DAI Jin-zhao.Clinical Value of Strontium-89 Combined with 99Tc-MDP in Treatment of Bone Metastases of Prostate Cancer[J].Labeled Immunoassays and Clinical Medicine,2011,18(4):241-243.
Authors:ZHU Wen-ru  ZHENG Fei-bo  LIU Bing-ji  DAI Jin-zhao
Institution:ZHU Wen-ru,ZHENG Fei-bo,LIU Bing-ji,DAI Jin-zhao(Department of Nuclear Medicine,the Second Affiliated Hospital of Qingdao University Medical College,Qingdao 266042,China)
Abstract:To evaluate the clinical value of 89Sr combined with 99Tc-MD Pin treatment of multiple bone metastases of prostate cancer,95 patients with bone metastases of prostate cancer were divided into group A and group B.46 patients in group A were treated with 89Sr only,the other 49 patients in group B were treated with 89Sr combined with 99Tc-MDP.Pain palliation,the changes of bone imaging and PSA level for all patients were observed and followed up.The results showed that the total effective rate of pain palliati...
Keywords:89Sr  99Tc-MDP  Bone metastases  Prostate cancer  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号